Trials / Unknown
UnknownNCT01227122
NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure
Plasmatic Level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictive Marker of Acute Kidney Failure in Patients With Preoperative Chronic Kidney Failure Undergoing Cardiac Surgery.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Hopital Jean Minjoz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary endpoint: To evaluate predictive value of plasmatic levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) to reveal acute kidney failure after cardiac surgery in patients with preoperative chronic kidney failure Secondary endpoint is to obtain threshold values of NGAL.
Detailed description
(N/A)
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2013-07-01
- Completion
- 2013-09-01
- First posted
- 2010-10-25
- Last updated
- 2013-03-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01227122. Inclusion in this directory is not an endorsement.